Clinical trial
Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney…
NCT00305396 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00305396 |
|---|---|
| Title | Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation |
| Official title | Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplant Recipients. |
| Lead sponsor | Vanderbilt University, Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Sirolimus |
| Enrollment | 80 |
| Start date | Apr 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Mar 21, 2006 |
| Last update posted | Mar 21, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: